Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Catégorie d'article: Research Article

Publié en ligne: 21 févr. 2018

Pages: 281 - 288

Reçu: 22 nov. 2017

Accepté: 30 nov. 2017

DOI: https://doi.org/10.2478/raon-2018-0009

Mots clés

locally advanced NSCLC, survival, immunotherapy, PD-L1 expression, chemoradiotherapy

© 2018 Martina Vrankar, Karmen Stanic, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.